LEAP2 and obesity disorder: Finally, we investigated whether, and how, intestinal Leap2 expression is altered in mouse models of obesity/type 2 diabetes and how such alterations relate to those of the eCBome in the same models, where profound gut microbiota perturbations, sometimes referred to as dysbiosis, also exist.